secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001437749-24-002692
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene receives Nasdaq extension to July 29, 2024 to cure $1 bid price deficiency; reverse split considered
--------------------------------------------------------------------------------

- Company failed to regain compliance by original Jan 29, 2024 deadline for minimum $1/share bid price.
- Nasdaq granted additional 180-day period until July 29, 2024; shares continue trading on Nasdaq under CLNN.
- Clene intends to cure deficiency, including via a reverse stock split if necessary.
- If bid price does not close at $1.00+ for 10 consecutive business days by July 29, 2024, delisting may occur.
- Company must also maintain market value of publicly held shares and other listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774924002692/0001437749-24-002692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774924002692/clnn20240130_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-002692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer